See more : CEZ, a. s. (CEZ.PR) Income Statement Analysis – Financial Results
Complete financial analysis of Envoy Medical, Inc. (COCH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Envoy Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Gold Bull Resources Corp. (GBRCF) Income Statement Analysis – Financial Results
- EPCO Co.,Ltd. (2311.T) Income Statement Analysis – Financial Results
- Bloom Dekor Limited (BLOOM.BO) Income Statement Analysis – Financial Results
- PagSeguro Digital Ltd. (PAGS) Income Statement Analysis – Financial Results
- Guararapes Confecções S.A. (GUAR3.SA) Income Statement Analysis – Financial Results
Envoy Medical, Inc. (COCH)
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 316.00K | 237.00K | 310.00K | 0.00 |
| Cost of Revenue | 789.00K | 957.00K | 769.00K | 0.00 |
| Gross Profit | -473.00K | -720.00K | -459.00K | 0.00 |
| Gross Profit Ratio | -149.68% | -303.80% | -148.06% | 0.00% |
| Research & Development | 8.96M | 4.52M | 3.94M | 0.00 |
| General & Administrative | 7.28M | 3.47M | 2.47M | 0.00 |
| Selling & Marketing | 1.67M | 885.00K | 0.00 | 0.00 |
| SG&A | 8.94M | 3.47M | 2.47M | 701.00 |
| Other Expenses | 0.00 | -7.22M | -1.80M | 0.00 |
| Operating Expenses | 17.90M | 7.99M | 6.41M | 701.00 |
| Cost & Expenses | 18.69M | 8.94M | 7.18M | 701.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 133.00K | 75.00K | 71.00K | 206.30K |
| EBITDA | -18.24M | -8.63M | -6.80M | -700.00 |
| EBITDA Ratio | -5,771.52% | -3,641.77% | -2,193.55% | 0.00% |
| Operating Income | -18.37M | -8.71M | -6.87M | -700.00 |
| Operating Income Ratio | -5,813.61% | -3,673.42% | -2,216.45% | 0.00% |
| Total Other Income/Expenses | -11.54M | -7.22M | -1.80M | -1.00 |
| Income Before Tax | -29.91M | -15.92M | -8.68M | -701.00 |
| Income Before Tax Ratio | -9,464.56% | -6,718.57% | -2,798.39% | 0.00% |
| Income Tax Expense | 0.00 | -153.49K | -165.56K | -206.30K |
| Net Income | -29.91M | -15.92M | -8.68M | -701.00 |
| Net Income Ratio | -9,464.56% | -6,718.57% | -2,798.39% | 0.00% |
| EPS | -2.38 | -1.57 | -0.85 | 0.00 |
| EPS Diluted | -2.38 | -1.57 | -0.85 | 0.00 |
| Weighted Avg Shares Out | 12.55M | 10.15M | 10.15M | 60.38M |
| Weighted Avg Shares Out (Dil) | 12.55M | 10.15M | 10.15M | 60.38M |
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
WHITE BEAR LAKE, Minn., June 11, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH) today announced the appointment of Michael Crowe to the Envoy Medical Board of Directors effective June 7, 2024. Envoy Medical is currently sponsoring...
Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
WHITE BEAR LAKE, MN, June 06, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, announces that MSCI has selected the Company's shares for inclusion in its...
Enovis (NYSE:ENOV) vs. Envoy Medical (NASDAQ:COCH) Financial Survey
Enovis (NYSE:ENOV – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst...
Envoy Medical Is Pursuing Filling A Hearing Industry Void
Envoy Medical is a hearing device company that offers fully implantable devices for people with moderate to severe hearing loss. The company's second device, Acclaim, has been granted Breakthrough Device status and is about to begin clinical trials for FDA...
Envoy Medical Reports First Quarter 2024 Results
The Company, a current leader in fully implanted hearing devices, continues to steadily march towards its ambition of disrupting the existing cochlear implant industry with its “breakthrough” fully implanted cochlear implant.
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
NEW YORK , April 20, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have...
COCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
NEW YORK , April 15, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
NEW YORK , April 3, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have...
Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024
WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R....
Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Company Provides Corporate Update that Include Updates on its Investigational Fully Implanted Acclaim® Cochlear Implant Meeting its Early Feasibility Study Milestones
Source: https://incomestatements.info
Category: Stock Reports